Stephen Hauser From University of California San Francisco: Ocrelizumab Provides Potential Answer to Difficult Treatment Questions

With doctors unable to prescribe an effective treatment for patients with progressive multiple sclerosis, an unanswered question has lingered for many years. A potential answer to this difficult question could be closer to reality than ever before.

Stephen L. Hauser, MD, who chairs the neurology departmen at the University of California San Francisco School of Medicine discussed this potential new treatment during the ACTRIMS conference in New Orleans. While not yet approved by the US Food and Drug Administration Hauser said even the potential treatment was an exciting step forward in the field.